Cite
2748. Single Intranasal (IN) Dose of M2SR (M2-Deficient Single Replication) Live Influenza Vaccine Protects Adults Against Subsequent Challenge with a Substantially Drifted H3N2 Strain.
MLA
Eiden, Joseph, et al. “2748. Single Intranasal (IN) Dose of M2SR (M2-Deficient Single Replication) Live Influenza Vaccine Protects Adults Against Subsequent Challenge with a Substantially Drifted H3N2 Strain.” Open Forum Infectious Diseases, vol. 6, Oct. 2019, pp. S967–68. EBSCOhost, https://doi.org/10.1093/ofid/ofz360.2425.
APA
Eiden, J., Volckaert, B., Rudenko, O., Ellis, R., Aitchison, R., Herber, R., Belshe, R., Greenberg, H., Coelingh, K., Kawaoka, Y., Neumann, G., & Bilsel, P. (2019). 2748. Single Intranasal (IN) Dose of M2SR (M2-Deficient Single Replication) Live Influenza Vaccine Protects Adults Against Subsequent Challenge with a Substantially Drifted H3N2 Strain. Open Forum Infectious Diseases, 6, S967–S968. https://doi.org/10.1093/ofid/ofz360.2425
Chicago
Eiden, Joseph, Bram Volckaert, Oleg Rudenko, Ruth Ellis, Roger Aitchison, Renee Herber, Robert Belshe, et al. 2019. “2748. Single Intranasal (IN) Dose of M2SR (M2-Deficient Single Replication) Live Influenza Vaccine Protects Adults Against Subsequent Challenge with a Substantially Drifted H3N2 Strain.” Open Forum Infectious Diseases 6 (October): S967–68. doi:10.1093/ofid/ofz360.2425.